Dermatology Clinical Trials

Recruiting dermatology studies with sites across the US, sourced from ClinicalTrials.gov and refreshed daily. Free to join — find one near you below.

Clinical trials study new ways to prevent, detect, or treat dermatology. Joining one can give you access to investigational treatments and close monitoring by a specialist research team — at no cost — while helping advance care for others. Below are recruiting dermatology studies with sites across the US; use the location tools to find ones near you.

What to expect

Screening first. The study team reviews your eligibility before anything else — there's no obligation to continue.
Informed consent. You'll get a full explanation of the study, its potential risks and benefits, and can withdraw at any time.
No cost to you. Study visits, tests, and the investigational treatment are covered; many studies reimburse travel.

Recruiting dermatology trials

Within

Effect of S. Aureus Skin Decolonization on Disease Severity in Atopic Dermatitis Patients

for Atopic Dermatitis

1 site in Boston

Sponsor: Boston Children's Hospital

Sex: All·Age: 6+

Code: NCT06397781·Phase 4

A Trial of Locoregionally Advanced Squamous Cell Carcinoma of The Head and Neck

for Squamous Cell Carcinoma

1 site in Chicago

Sponsor: University of Chicago

Sex: All·Age: 18+

Code: NCT07346196·Phase 2

Phase 1 Study Of TROP2 CAR/IL-15 TGFBR2 KO NK Cell In Patients With Oral Premalignant Lesions

for Squamous Cell Carcinoma

1 site in Houston

Sponsor: M.D. Anderson Cancer Center

Sex: All·Age: 18+

Code: NCT07631013·Phase 1

Aggressive Lipid Lowering Therapy in ICI-Treated Melanoma

for Melanoma

1 site in Aurora

Sponsor: University of Colorado, Denver

Sex: All·Age: 55+

Code: NCT07704918

A Study To Assess the Safety, and Tolerability of Nivolumab + Relatlimab Fixed-Dose Combination (FDC) In Untreated, Unresectable or Metastatic Melanoma Participants In India

for Untreated Melanoma

Sponsor: Bristol-Myers Squibb

Sex: All·Age: 12+

Code: NCT07459543·Phase 4

Feasibility of an Enhanced Symptom Monitoring and Expedited Subspecialty Care Referral Intervention to Improve Side Effect Management for Patients With Melanoma Receiving an Immune Checkpoint Inhibitor

for Melanoma

1 site in Portland

Sponsor: OHSU Knight Cancer Institute

Sex: All·Age: 18+·Accepts healthy volunteers

Code: NCT07660666

A Study of Early Secukinumab Treatment in Moderate to Severe Hidradenitis Suppurativa Patients

for Hidradenitis Suppurativa

Sponsor: Novartis Pharmaceuticals

Sex: All·Age: 18+

Code: NCT07690319

Omission of Postoperative Radiation in HPV-Associated Oropharyngeal Cancer Using ctHPVDNA Surveillance (OPERATION)

for Squamous Cell Carcinoma

1 site in Charleston

Sponsor: Medical University of South Carolina

Sex: All·Age: 18+

Code: NCT07513389·Phase 2

Apply to this trial

Evaluation of Serum IL-41 Level in Patients With Ankylosing Spondylitis and Psoriatic Arthritis

for Ankylosing Spondylitis

Sponsor: Assiut University

Sex: All·Age: 18+·Accepts healthy volunteers

Code: NCT07648836

Immune Checkpoint Inhibitor (ICI)-Drug-Drug Interaction (DDI) Study

for Gastrointestinal Neoplasms

1 site in Indianapolis

Sponsor: Indiana University

Sex: All·Age: 18+

Code: NCT07389525·EARLY_Phase 1

A Randomised Controlled Trial of ePROM-Guided Flexible Scheduling in Dermatology

for Chronic Dermatological Conditions

Sponsor: National University Hospital, Singapore

Sex: All·Age: 16+

Code: NCT07481019

MELCHRONO: A Prospective Randomized Study Investigating Chrono-immunotherapy for Advanced Melanoma.

for Melanoma

Sponsor: Swiss Cancer Institute

Sex: All·Age: 18+

Code: NCT07574047·Phase 4

PROSECCO: A Phase 2, Single Arm, Neoadjuvant Study Evaluating Combination Cemiplimab, Fianlimab, And Ipilimumab In Patients With Surgically Resectable Melanoma

for Melanoma

1 site in Houston

Sponsor: M.D. Anderson Cancer Center

Sex: All·Age: 18+

Code: NCT07511036·Phase 2

Nailfold Capillaroscopic Changes in Psoriasis

for Psoriasis

Sponsor: Al-Azhar University

Sex: All·Age: All ages

Code: NCT07693595

Dose Ranging, Toxicity Seeking, Phase 1 Trial of Oncolytic Adenoviral Therapy for Melanoma Intracranial and Extracranial Metastases

for Melanoma

1 site in Houston

Sponsor: M.D. Anderson Cancer Center

Sex: All·Age: 18+

Code: NCT07444606·Phase 1

The ROOT Study: Scaling the 'Standard of Care Plus' Obstetric Nutrition Model to Optimize Maternal and Infant Health

for Preterm Birth

Sponsor: GrowBaby Life Project

Sex: Female·Age: 18+

Code: NCT07559773

Combining Neo-adjuvant ATR-inhibition With Nodal SBRT for Early-stage Resectable HPV+ OPSCCs

for HPV Positive Oropharyngeal Squamous Cell Carcinoma

Sponsor: Abramson Cancer Center at Penn Medicine

Sex: All·Age: 18+

Code: NCT07578467·Phase 1, Phase 2

Opzelura Experience Study

for Atopic Dermatitis

1 site in Winston-Salem

Sponsor: Wake Forest University Health Sciences

Sex: All·Age: 2+

Code: NCT07661979·Phase 4

Efficacy and Tolerability of a Probiotic Ointment

for Atopic Dermatitis

Sponsor: BioGaia AB

Sex: All·Age: 6 Months - 15

Code: NCT07701447

Combined Fractional CO₂ Laser and Topical Corticosteroid Versus Topical Corticosteroid Only in the Treatment of Palmoplantar Psoriasis

for Psoriasis

Sponsor: Cairo University

Sex: All·Age: 18 - 60

Code: NCT07713212·Phase 4

Dermoscopy Augmented Histology Trial, a Randomized Controlled Trial

for Melanoma

Sponsor: Herlev Hospital

Sex: All·Age: All ages·Accepts healthy volunteers

Code: NCT05004792

Utilization of a Microdevice for Psoriasis and Atopic Dermatitis

for Psoriasis

1 site in San Francisco

Sponsor: University of California, San Francisco

Sex: All·Age: 18+

Code: NCT07352566·Phase 4

Timing of Immunotherapy in Melanoma

for Melanoma

Sponsor: Radboud University Medical Center

Sex: All·Age: 18+

Code: NCT07696715

Azithromycin in Atopic Dermatitis

for Atopic Dermatitis

Sponsor: Cairo University

Sex: All·Age: 3 - 12

Code: NCT07713186·Phase 4

Neoadjuvant Ipilimumab/Nivolumab for Patients With Recurrent, High Risk, Resectable Melanoma

for Melanoma

1 site in Salt Lake City

Sponsor: University of Utah

Sex: All·Age: 18+

Code: NCT06365619·Phase 2

Apply to this trial

Hepzato Kit and Opdualag for Metastatic Melanoma and Liver Metastasis

for Metastatic Melanoma

1 site in Madison

Sponsor: University of Wisconsin, Madison

Sex: All·Age: 18+

Code: NCT07281924·Phase 1, Phase 2

Apply to this trial

Assessing Psoriasis Treatment Outcomes

for Psoriasis

1 site in Winston-Salem

Sponsor: Wake Forest University Health Sciences

Sex: All·Age: 18+

Code: NCT07391423

Cosibelimab for CSCC in Patients With Kidney Transplant or Hematologic Malignancy

for Cutaneous Squamous Cell Carcinoma

2 sites in Boston

Sponsor: Dana-Farber Cancer Institute

Sex: All·Age: 18+

Code: NCT07426484·Phase 4

A Real-world Study of Patients With Hidradenitis Suppurativa and High Cardiovascular Risk or Established Coronary Plaque Treated With Secukinumab

for Hidradenitis Suppurativa

Sponsor: Novartis Pharmaceuticals

Sex: All·Age: 18 - 75

Code: NCT07454889

Personalized Cancer Support (Thrive Track) to Manage the Emotional Needs of Young Adults With Thyroid, Melanoma and Testicular Cancer, PerCS-YA Trial

for Differentiated Thyroid Gland Carcinoma

1 site in Ann Arbor

Sponsor: University of Michigan Rogel Cancer Center

Sex: All·Age: 20 - 39

Code: NCT07529080

A Clinical Study of HRS-8797 in Healthy Participants

for Atopic Dermatitis

Sponsor: Chengdu Suncadia Medicine Co., Ltd.

Sex: All·Age: 18 - 55·Accepts healthy volunteers

Code: NCT07698756·Phase 1

Clinical Genetics Branch Eligibility Screening Survey

for Melanoma

1 site in Rockville

Sponsor: National Cancer Institute (NCI)

Sex: All·Age: 1 - 99

Code: NCT07005297

Evaluating the Safety and Tolerability of Baricitinib in Patients With Job Syndrome With Lupus-Like Disease and/or Atopic Dermatitis

for Hyper IgE Syndrome From STAT3 Mutation

1 site in Bethesda

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Sex: All·Age: 12 - 120

Code: NCT07262983·Phase 1

Apply to this trial

Natural History Study of Early Life Exposures in Agriculture (ELEA)

for Prostate Cancer

1 site in Bethesda

Sponsor: National Cancer Institute (NCI)

Sex: All·Age: 18 - 99·Accepts healthy volunteers

Code: NCT07328516

An Extension Study to Assess Safety and Efficacy of Remibrutinib in Participants With Moderate to Severe HS

for Hidradenitis Suppurativa

Sponsor: Novartis Pharmaceuticals

Sex: All·Age: 18 - 100

Code: NCT07665437·Phase 3

Apply to this trial

Impact of Dysport on PMFF Donor Scar

for Skin Cancer Excision Site

1 site in Nashville

Sponsor: Vanderbilt University Medical Center

Sex: All·Age: 18+

Code: NCT07720726·Phase 4

Crisaborole 2% Versus Tacrolimus 0.1% in Children With Mild to Moderate Atopic Dermatitis

for Atopic Dermatitis

Sponsor: Shalamar Institute of Health Sciences

Sex: All·Age: 2 - 18

Code: NCT07162896·Phase 3

Study of ADSTEM Injection for Patients With Moderate to Severe Subacute and Chronic Atopic Dermatitis

for Atopic Dermatitis

Sponsor: EHL Bio Co., Ltd.

Sex: All·Age: 19 - 70

Code: NCT07377838·Phase 3

Metformin Combined With Secukinumab for Moderate-to-Severe Plaque Psoriasis in Overweight or Obese Chinese Patients

for Psoriasis

Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

Sex: All·Age: 18 - 75

Code: NCT07485764·Phase 4

A Study of HLX18 vs. OPDIVO® in Multiple Resected Solid Tumors

for Esophageal and/or Cardia Cancer

Sponsor: Shanghai Henlius Biotech

Sex: All·Age: 18 - 70

Code: NCT07518043·Phase 1

A Study of IDP-001 in Advanced or Metastatic Solid Tumors

for Advanced Solid Tumor

1 site in Edison

Sponsor: InduPro, Inc.

Sex: All·Age: 18+

Code: NCT07602842·Phase 1, Phase 2

A Phase 2b Dose-Ranging Study to Evaluate the Efficacy and Safety of ENV-294 in Adults With Moderate-to-Severe Atopic Dermatitis

for Atopic Dermatitis

1 site in Encinitas

Sponsor: Enveda Therapeutics

Sex: All·Age: 18+

Code: NCT07643766·Phase 2

The Impact of Dietary Salt on the Severity of Eczema

for Eczema

2 sites in San Francisco

Sponsor: University of California, San Francisco

Sex: All·Age: 18+·Accepts healthy volunteers

Code: NCT07447063·Phase 4

The Impact of Salt Intake on Sodium in the Skin and Inflammatory Skin Disease

for Atopic Dermatitis (Eczema)

2 sites in San Francisco

Sponsor: University of California, San Francisco

Sex: All·Age: 18+·Accepts healthy volunteers

Code: NCT07487831·Phase 4

A Randomized, Double-Blind, Pharmacokinetic Similarity Study to Compare AVT32-DRL_PB With Keytruda® in Participants With Fully Resected Melanoma

for Melanoma

Sponsor: Alvotech Swiss AG

Sex: All·Age: 18+

Code: NCT07475572·Phase 1

Developing and Testing the Effectiveness of a Skin Cancer Self-Detection Educational Program

for Skin Cancer

Sponsor: National University Hospital, Singapore

Sex: All·Age: 16+·Accepts healthy volunteers

Code: NCT07247123

Apply to this trial

Pentoxifylline Add-On Therapy for Mild-to-Moderate Plaque Psoriasis

for Psoriasis

Sponsor: Wasuchon Chaichan

Sex: All·Age: 18 - 65

Code: NCT07626788

A Study to Assess Concentration of TREMFYA in Breast Milk of Lactating Women Who Are Receiving TREMFYA Therapeutically

for Psoriasis

1 site in Chapel Hill

Sponsor: Janssen Research & Development, LLC

Sex: Female·Age: 18+

Code: NCT07654751·Phase 4

Dietary Fiber to Induce Gut Microbiota-mediated Response to Immunotherapy in Melanoma.

for Melanoma (Skin) Stage IV

Sponsor: Radboud University Medical Center

Sex: All·Age: 18+

Code: NCT07686835·Phase 2

Morning Versus Afternoon Administration of Immunotherapy for the Treatment of Advanced or Metastatic Solid Tumors, The Knight SHIFT Study

for Advanced Biliary Tract Carcinoma

1 site in Portland

Sponsor: OHSU Knight Cancer Institute

Sex: All·Age: 18+

Code: NCT07405086·Phase 4

Apply to this trial

A Study to Evaluate D-2570 in Participants With Moderate to Severe Plaque Psoriasis

for Psoriasis

20 sites incl. Birmingham

Sponsor: InventisBio Co., Ltd

Sex: All·Age: 18 - 70

Code: NCT07489885·Phase 2

Apply to this trial

Pharmacokinetics, Safety, and Immunogenicity Comparison of Bmab1700 and Opdivo® as Adjuvant Monotherapy in Participants With Melanoma

for Melanoma

Sponsor: Biocon Biologics UK PLC

Sex: All·Age: 18+

Code: NCT07476326·Phase 1

A Randomized Controlled Trial Comparing the Effectiveness and Safety of Topical Tacrolimus 0.03% Versus Crisaborole 2% in Patients With Mild to Moderate Atopic Dermatitis Over 8 Weeks

for Atopic Dermatitis

Sponsor: Foundation University Islamabad

Sex: All·Age: 2 - 20

Code: NCT07519174

A Multicenter, Randomized, Double-blind, Vehicle Controlled Phase II Clinical Study to Evaluate the Efficacy and Safety of VC005 Gel in Adult Subjects With Mild to Moderate Atopic Dermatitis

for Atopic Dermatitis

Sponsor: Jiangsu vcare pharmaceutical technology co., LTD

Sex: All·Age: 18+

Code: NCT07598383·Phase 2

Apply to this trial

Effects of Different Secukinumab Maintenance Regimens on Long-Term Outcomes in Patients With Psoriasis

for Psoriasis

Sponsor: The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School

Sex: All·Age: 18+

Code: NCT07642544

PPD™ CorEvitas™ Psoriasis (PSO) Early Treatment Response Non-Interventional Study

for Psoriasis

2 sites in Waltham

Sponsor: CorEvitas

Sex: All·Age: 18+·Accepts healthy volunteers

Code: NCT07648602

Apply to this trial

Evaluation the Topical Apremilast Nanoformulation in Treatment of Localized Plaque Psoriasis

for Psoriasis

Sponsor: Assiut University

Sex: All·Age: 18+

Code: NCT07366268

Psoriasis Comorbidities at Hospital Calderón Guardia

for Psoriasis

Sponsor: Caja Costarricense de Seguro Social

Sex: All·Age: 12+

Code: NCT07448337

Atopic Dermatitis Treated With Dupilumab and JAK Inhibitors in Costa Rica

for Atopic Dermatitis

Sponsor: Caja Costarricense de Seguro Social

Sex: All·Age: All ages

Code: NCT07448363

Costa Rican Registry of IL-23 Inhibitors in Psoriatic Disease

for Psoriasis

Sponsor: Caja Costarricense de Seguro Social

Sex: All·Age: 12+

Code: NCT07448402

Dermatology clinical trials — common questions

Are dermatology clinical trials free to join?

Yes. Participating in a dermatology clinical trial is free — study-related visits, tests, and the investigational treatment are provided at no cost to you. Many studies also reimburse travel and time. You never pay to take part.

Who can join a dermatology clinical trial?

Each dermatology study sets its own eligibility criteria — typically based on age, medical history, current treatments, and overall health. Every trial listed here shows its criteria, and the study team confirms your eligibility before enrollment. You can review and apply to any that look like a fit.

How do I find a dermatology trial near me?

Use the location controls above. We'll show recruiting dermatology trials with sites near you, sorted by distance. You can widen the radius or share your exact location for the closest matches.

How many dermatology trials are recruiting right now?

We're currently tracking roughly 325 recruiting dermatology trials with US sites, sourced from ClinicalTrials.gov and refreshed daily.

Looking for a specific location? Browse trials by city and state.

Dermatology trials by city

Birmingham, AL San Francisco, CA Boston, MA Los Angeles, CA Tampa, FL Columbus, OH Sacramento, CA Chicago, IL Duarte, CA La Jolla, CA Orange, CA Ann Arbor, MI

Conditions in this area

Psoriasis Atopic dermatitis / eczema Hidradenitis suppurativa Melanoma Skin cancer